Treatment of psoriatic arthritis with tumor necrosis factor inhibitors: longer-term outcomes including enthesitis and dactylitis with golimumab treatment in the Longterm Extension of a Randomized, Placebo-controlled Study (GO-REVEAL).

scientific article published in July 2012

Treatment of psoriatic arthritis with tumor necrosis factor inhibitors: longer-term outcomes including enthesitis and dactylitis with golimumab treatment in the Longterm Extension of a Randomized, Placebo-controlled Study (GO-REVEAL). is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3899/JRHEUM.120254
P698PubMed publication ID22751603

P50authorArthur KavanaughQ93106996
P2093author name stringPhilip Mease
P921main subjectpsoriatic arthritisQ511097
DactylitisQ517782
enthesitisQ3055079
P304page(s)90-93
P577publication date2012-07-01
P1433published inThe Journal of rheumatology. SupplementQ27711737
P1476titleTreatment of psoriatic arthritis with tumor necrosis factor inhibitors: longer-term outcomes including enthesitis and dactylitis with golimumab treatment in the Longterm Extension of a Randomized, Placebo-controlled Study (GO-REVEAL).
P478volume89

Reverse relations

cites work (P2860)
Q38236514A review of disease activity measures for psoriatic arthritis: what is the best approach?
Q99238557An Update for the Clinician on Biologics for the Treatment of Psoriatic Arthritis
Q46134997Clinical Characteristics, Disease Activity, and Patient-Reported Outcomes in Psoriatic Arthritis Patients With Dactylitis or Enthesitis: Results From the Corrona Psoriatic Arthritis/Spondyloarthritis Registry.
Q35931950Erythrodermic Psoriasis Treated with Golimumab: A Case Report
Q90468513GO-DACT: a phase 3b randomised, double-blind, placebo-controlled trial of GOlimumab plus methotrexate (MTX) versus placebo plus MTX in improving DACTylitis in MTX-naive patients with psoriatic arthritis
Q55424021Golimumab: A Novel Anti-Tumor Necrosis Factor.
Q90893942Pathophysiology, assessment and treatment of psoriatic dactylitis
Q38667430Pharmacological treatment of psoriatic arthritis: a systematic literature review for the 2015 update of the EULAR recommendations for the management of psoriatic arthritis
Q30240183Risk of infections using anti-TNF agents in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: a systematic review and meta-analysis.
Q26764867Tailored treatment options for patients with psoriatic arthritis and psoriasis: review of established and new biologic and small molecule therapies
Q55690278Therapeutic benefit of apremilast on enthesitis and dactylitis in patients with psoriatic arthritis: a pooled analysis of the PALACE 1–3 studies.
Q38204241Treatment of psoriatic arthritis with anti-TNF agents: a systematic review and meta-analysis of efficacy, effectiveness and safety
Q92737085What does evidence-based medicine tell us about treatments for different subtypes of psoriatic arthritis? A systematic literature review on randomized controlled trials
Q52927228[Psoriatic arthritis : Overview of drug therapy options and administration characteristics].
Q53760739[Psoriatic arthritis : Overview of drug therapy options and administration characteristics].

Search more.